Amy VanBuskirk, the new General Manager of Roche in Italy, warns that the country is becoming less competitive due to a significant 30% decrease in drug studies and the long timelines for patient enrollment, which could lead to a potential silent relocation of investments. #Oncologia #RicercaClinica #InnovazioneFarmaceutica (translated)

